Search - tctmd.com

Displaying 541 - 560 of 786

Sort: Relevancy | Date

News Industry News

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

October 24, 2012

News Industry News

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

October 24, 2012

News Industry News

PROMUS Element™ and PROMUS Element™ Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy

October 24, 2012

News Industry News

Mesh-Covered Stent Improves Restoration of Blood Flow in Heart Attack Patients Undergoing Angioplasty

October 24, 2012

Presentation TCT 2012

TCT-75. Lumen Enlargement of the Coronary Segments Located Distal to Chronic Total Occlusions Successfully Treated with Drug-Eluting Stents at Follow-up

Presenter: Josep Gomez-Lara

October 23, 2012

Presentation TCT 2012

Bare Metal vs. Drug-Eluting Stents: Mechanisms of Action and Comparative Effectiveness and Safety

Presenter: Ajay Kirtane

October 23, 2012

Presentation TCT 2012

Progress with Drug-Eluting Magnesium Resorbing Stents (BIOTRONIK): DREAMS 2-Year Results

Presenter: Michael Haude

October 23, 2012

News Industry News

Micell Technologies Announces Positive Data from Clinical Studies of MiStent SES

October 23, 2012

Presentation TCT 2012

After CTO Recanalization, What Is the Role of Drug-Eluting Devices, Covered Stents, Etc?

Presenter: Thomas Zeller

October 23, 2012

Presentation TCT 2012

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro!

Presenter: Gary Ansel

October 22, 2012

News Conference News TCT 2012

Several Trials Highlight DES Comparisons

October 22, 2012

News Conference News TCT 2012

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

October 22, 2012

News Industry News

IDEV Presents Consistent Evidence Validating the Mimetic Design of SUPERA® Stent

October 22, 2012

Presentation TCT 2012

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Con!

Presenter: Lawrence Garcia

October 22, 2012

News Industry News

Analysis Of Medtronic Stent Finds Early Cessation Of Dual Antiplatelet Therapy Caused No Increased Risk Of Blood Clots To One Year

October 22, 2012

News Industry News

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2)

October 16, 2012

News Industry News

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012

October 16, 2012

News Daily News

Registry Confirms Long-Term Survival Higher in Women After Stenting

Yael L. Maxwell

October 05, 2012

News Daily News

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Jason Kahn

October 05, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

Advertisement

Second Generation Drug-Eluting Stents are Safe and Effective in Treatment of Left Main Coronary Artery Disease

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

PROMUS Element™ and PROMUS Element™ Plus Receive CE Mark Approval for Labeling Update to Include Three-Month Dual Anti-Platelet Therapy

Mesh-Covered Stent Improves Restoration of Blood Flow in Heart Attack Patients Undergoing Angioplasty

TCT-75. Lumen Enlargement of the Coronary Segments Located Distal to Chronic Total Occlusions Successfully Treated with Drug-Eluting Stents at Follow-up

Bare Metal vs. Drug-Eluting Stents: Mechanisms of Action and Comparative Effectiveness and Safety

Progress with Drug-Eluting Magnesium Resorbing Stents (BIOTRONIK): DREAMS 2-Year Results

Micell Technologies Announces Positive Data from Clinical Studies of MiStent SES

After CTO Recanalization, What Is the Role of Drug-Eluting Devices, Covered Stents, Etc?

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Pro!

Several Trials Highlight DES Comparisons

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

IDEV Presents Consistent Evidence Validating the Mimetic Design of SUPERA® Stent

Debate I. Are Drug-Eluting Stents Now the Default Strategy for SFA Intervention? - Con!

Analysis Of Medtronic Stent Finds Early Cessation Of Dual Antiplatelet Therapy Caused No Increased Risk Of Blood Clots To One Year

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012(2)

OrbusNeich’s COMBO Dual Therapy Stent™ to be Featured in Multiple Clinical Data Presentations Next Week at TCT 2012

Registry Confirms Long-Term Survival Higher in Women After Stenting

Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content